Business Case

Developed a targeting approach based on identification and definition of key HCP segments to inform a go-to-market strategy

Our client, a large ophthalmology company, aimed to comprehensively understand key customer segments to fine-tune their go-to-market strategy for a novel ophthalmologic, eyedrop-formulated therapy. LSC, leveraging a blend of qualitative and quantitative approaches assessed prescribing behaviors, dove deep into HCP research to map behavioral and psychographic patterns, and used algorithms to validate and profile HCP segments, culminating in a sophisticated tool to guide future market research and targeting. As a result, not only was LSC able to pinpoint product favorability across segments through claims analysis and quantitative studies, but we also equipped our client with a simulator, enabling them to model preference shares and estimate market dominancy by segment, ensuring a strategically-sound market entry.